Milford Funds’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.6M Sell
2,169,484
-40,737
-2% -$2.21M 1.51% 19
2026
Q1
$139M Buy
2,210,221
+1,394,942
+171% +$112M 2.91% 12
2025
Q4
$77.7M Buy
+815,279
New +$79.9M 1.53% 25

Other funds holding BSX

Milford Funds's BSX Position: Q2 2026 in Review

Milford Funds reduced its Boston Scientific (BSX) stake by 1.8% in Q2 2026, selling an estimated $2.21M and leaving 2,169,484 shares worth $92.6M. The position accounts for 1.51% of the portfolio, ranked #19.

Milford Funds first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $139M in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Milford Funds held 2,169,484 shares of Boston Scientific worth $92.6M as of Q2 2026.
  • Milford Funds sold 40,737 Boston Scientific shares in Q2 2026, an estimated $2.21M.
  • Boston Scientific made up 1.51% of Milford Funds's portfolio in Q2 2026, its #19 holding.
  • Milford Funds first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Milford Funds's Boston Scientific position peaked at $139M in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Milford Funds's 13F filing for Q2 2026, filed 30 Jul 2026.